title: Fixed-dose combination and therapeutic drug monitoring in tuberculosis: friend or foe?
authors: University of Groningen, University Medical Center Groningen, Dept of Clinical Pharmacy and Pharmacology, Groningen, The Netherlands.
authors: Marlanka A
authors: MA
authors: Zuur
authors: University of Groningen, University Medical Center Groningen, Tuberculosis Center Beatrixoord, Haren, The Netherlands University of Groningen, University Medical Center Groningen, Dept of Pulmonary Diseases and Tuberculosis, Groningen, The Netherlands.
authors: Onno W
authors: OW
authors: Akkerman
authors: Unit of Infectious Diseases, Dept of Medicine Solna, Karolinska Institutet, Stockholm, Sweden Clinic of Infectious Diseases, Karolinska University Hospital Solna, Stockholm, Sweden.
authors: Lina
authors: L
authors: Davies Forsman
authors: Dept of Epidemiology, School of Public Health, Fudan University, Shanghai, China Key Laboratory of Public Health Safety (Fudan University), Ministry of Education, China.
authors: Yi
authors: Y
authors: Hu
authors: Dept of Tuberculosis Prevention, Xiamen City Center for Disease Control, Xiamen, China.
authors: Rongdong
authors: R
authors: Zheng
authors: Unit of Infectious Diseases, Dept of Medicine Solna, Karolinska Institutet, Stockholm, Sweden Clinic of Infectious Diseases, Karolinska University Hospital Solna, Stockholm, Sweden.
authors: Judith
authors: J
authors: Bruchfeld
authors: Division of Infection, Barts Health NHS Trust, London, UK.
authors: Simon
authors: S
authors: Tiberi
authors: World Health Organization Collaborating Centre for Tuberculosis and Lung Diseases, Fondazione S. Maugeri, Tradate, Italy.
authors: Giovanni Battista
authors: GB
authors: Migliori
authors: University of Groningen, University Medical Center Groningen, Dept of Clinical Pharmacy and Pharmacology, Groningen, The Netherlands j.w.c.alffenaar@umcg.nl.
authors: Jan-Willem C
authors: JC
authors: Alffenaar
mesh_terms: D000995:Antitubercular Agents / Q000627:therapeutic use*; D004338:Drug Combinations; D016903:Drug Monitoring; D006801:Humans; D007538:Isoniazid / Q000627:therapeutic use; D011718:Pyrazinamide / Q000627:therapeutic use; D012293:Rifampin / Q000627:therapeutic use; D014376:Tuberculosis / Q000188:drug therapy*
chemical_list: D000995:Antitubercular Agents; D004338:Drug Combinations; D011718:Pyrazinamide; D007538:Isoniazid; D012293:Rifampin